PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 46 filers reported holding PROFOUND MED CORP in Q3 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $690,856 | -15.2% | 67,731 | +8.2% | 0.00% | 0.0% |
| Q2 2023 | $814,504 | +49.5% | 62,606 | +6.7% | 0.00% | – |
| Q1 2023 | $544,961 | -46.4% | 58,661 | -37.2% | 0.00% | -100.0% |
| Q4 2022 | $1,016,603 | +360.0% | 93,352 | +70.9% | 0.00% | – |
| Q3 2022 | $221,000 | -50.7% | 54,611 | -11.2% | 0.00% | – |
| Q2 2022 | $448,000 | -17.9% | 61,481 | +1.4% | 0.00% | – |
| Q1 2022 | $546,000 | -34.5% | 60,646 | -18.0% | 0.00% | -100.0% |
| Q4 2021 | $834,000 | -12.9% | 73,927 | +12.5% | 0.00% | 0.0% |
| Q3 2021 | $958,000 | +7.9% | 65,696 | +20.4% | 0.00% | 0.0% |
| Q2 2021 | $888,000 | +24.7% | 54,560 | +53.7% | 0.00% | 0.0% |
| Q1 2021 | $712,000 | +61.5% | 35,506 | +65.6% | 0.00% | – |
| Q4 2020 | $441,000 | +7.0% | 21,440 | -8.5% | 0.00% | -100.0% |
| Q3 2020 | $412,000 | +312.0% | 23,421 | +125.2% | 0.00% | – |
| Q1 2020 | $100,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 341,767 | $7,029,000 | 13.80% |
| GAGNON SECURITIES LLC | 821,196 | $16,883,000 | 2.69% |
| Gagnon Advisors, LLC | 277,252 | $5,700,000 | 2.56% |
| Taylor Wealth Management Partners | 166,294 | $3,419,000 | 1.32% |
| PCJ Investment Counsel Ltd. | 126,930 | $2,611,000 | 1.22% |
| EAM Global Investors LLC | 172,291 | $3,542,000 | 0.96% |
| AWM Investment Company, Inc. | 348,939 | $7,174,000 | 0.91% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $16,048,000 | 0.58% |
| Wealth Management Partners, LLC | 20,282 | $554,000 | 0.43% |
| Parkman Healthcare Partners LLC | 69,049 | $1,420,000 | 0.36% |